Research/art/teacher profile of a person
Name and surname:
doc. RNDr. Zuzana Danková, PhD.
Document type:
Research/art/teacher profile of a person
The name of the university:
Comenius University Bratislava
The seat of the university:
Šafárikovo námestie 6, 818 06 Bratislava

I. - Basic information

I.1 - Surname
Danková
I.2 - Name
Zuzana
I.3 - Degrees
doc. RNDr. PhD.
I.4 - Year of birth
1979
I.5 - Name of the workplace
Biomedical Centre Martin, Jessenius Faculty of Medicine, Comenius University Bratislava
I.6 - Address of the workplace
Malá hora 4C, Martin
I.7 - Position
Researcher
I.8 - E-mail address
zuzana.dankova@uniba.sk
I.9 - Hyperlink to the entry of a person in the Register of university staff
https://www.portalvs.sk/regzam/detail/5365?mode=full&do=filterForm-submit&name=Zuzana&surname=Dankov%C3%A1&university=701000000&faculty=701080000&sort=surname&employment_state=yes&filter=Vyh%C4%BEada%C5%A5
I.10 - Name of the study field in which a person works at the university
Obstetrics and Gynecology
I.11 - ORCID iD
https://orcid.org/0000-0003-4761-7553

II. - Higher education and further qualification growth

II.1 - First degree of higher education
II.a - Name of the university or institution
Faculty of Natural Sciences, Comenius University in Bratislava
II.b - Year
2001
II.c - Study field and programme
Biology
II.2 - Second degree of higher education
II.a - Name of the university or institution
Faculty of Natural Sciences, Comenius University in Bratislava
II.b - Year
2003
II.c - Study field and programme
Anthropology
II.3 - Third degree of higher education
II.a - Name of the university or institution
Faculty of Natural Sciences, Comenius University in Bratislava
II.b - Year
2007
II.c - Study field and programme
Anthropology
II.4 - Associate professor
II.a - Name of the university or institution
Faculty of Natural Sciences, Comenius University in Bratislava
II.b - Year
2018
II.c - Study field and programme
Biology
II.5 - Professor
II.6 - Doctor of Science (DrSc.)

III. - Current and previous employment

III.a - Occupation-position III.b - Institution III.c - Duration
Researcher Jessenius Faculty of Medicine, Comenius University Bratislava 01.02.2016-now
Researcher Faculty of Natural Sciences, Comenius University in Bratislava 15.01.2008-31.01.2016
Coordinator of EU Projects eRko-HKSH 01.07.2006-31.03.2012

IV. - Development of pedagogical, professional, language, digital and other skills

IV.a - Activity description, course name, other IV.b - Name of the institution IV.c - Year
Head of laboratory - quality manager ISO 15189:2012/2022, ISO/IEC 17025:2017 GENERI BIOTECH s.r.o. 2023
How to Operate a Biobank (Advanced course) Medical University of Graz 2022
English language course, B1 Academy of Education 2016
Certificate of professional competence to work with very toxic substances and mixtures and toxic substances and mixtures Public Health Authority of the Slovak Republic 2015
VKSIIa Slovak Academy of Sciences 2013
Doctoral Thesis Faculty of Natural Sciences, Comenius University in Bratislava 2009
ECDL certificate ECDL 2006

V. - Overview of activities within the teaching career at the university

V.1 - Overview of the profile courses taught in the current academic year according to study programmes
V.2 - Overview of the responsibility for the delivery, development and quality assurance of the study programme or its part at the university in the current academic year
V.3 - Overview of the responsibility for the development and quality of the field of habilitation procedure and inaugural procedure in the current academic year
V.4 - Overview of supervised final theses
V.4.1 - Number of currently supervised theses
V.4.a - Bachelor's (first degree)
0
V.4.b - Diploma (second degree)
0
V.4.c - Dissertation (third degree)
0
V.4.2 - Number of defended theses
V.4.a - Bachelor's (first degree)
3
V.4.b - Diploma (second degree)
5
V.4.c - Dissertation (third degree)
1
V.5 - Overview of other courses taught in the current academic year according to study programmes

VI. - Overview of the research/artistic/other outputs

VI.1 - Overview of the research/artistic/other outputs and the corresponding citations
VI.1.1 - Number of the research/artistic/other outputs
VI.1.a - Overall
125
VI.1.b - Over the last six years
51
VI.1.2 - Number of the research/artistic/other outputs registered in the Web of Science or Scopus databases
VI.1.a - Overall
57
VI.1.b - Over the last six years
32
VI.1.3 - Number of citations corresponding to the research/artistic/other outputs
VI.1.a - Overall
573
VI.1.b - Over the last six years
297
VI.1.4 - Number of citations registered in the Web of Science or Scopus databases
VI.1.a - Overall
489
VI.1.b - Over the last six years
265
VI.1.5 - Number of invited lectures at the international, national level
VI.1.a - Overall
0
VI.1.b - Over the last six years
0
VI.2 - The most significant research/artistic/other outputs
1

Gašparovič, J. - Rašlová, K. - Danková, Z. - Wsólová, L. - Avdičová, M. - Blažíček, P. - Lietava, J. - Zacharová, M. - Siváková, D. (2004). Effect of C677T Methylenetetrahydrofolate Reductase Gene Polymorphism on Plasma Homocysteine Levels in Ethnic Groups. Physiological Research. Vol. 53, No. 2, s. 215-218. 2003: 0,939-IF, Q4-JCR, Q2-SJR. Ohlasy: 19

2

Rašlová, K. - Dobiášová, M. - Hubáček, J. - Benčová, D. - Siváková, D. - Danková, Z. - Franeková, J. - Jabor, A. - Gašparovič, J. -Vohnout, B. (2011). Association of Metabolic and Genetic Factors with Cholesterol Esterification Rate in HDL Plasma and Atherogenic Index of Plasma in a 40 Years Old Slovak Population. Physiological Research. Vol. 60, No. 5, s. 785-795. 2010: 1,646-IF, Q3-JCR, Q2-SJR. Ohlasy: 23.

3

Gašparovič, J.* - Danková, Z.* - Fábryová, Ľ. - Wsólová, L. - Vohnout, B. - Rašlová, K. (2007). Familial defective apolipoprotein B-100 in Slovakia. Are differences inprevalence of familial defective apolipoprotein B-100 explained by ethnicity? Atherosclerosis. Vol. 194, No. 2, s. e95-e107. 2006: 3,811-IF, Q1-JCR, Q1-SJR. Ohlasy: 14.

4

Danková, Zuzana (Autor) [UKOLJ110C] (20%) - Braný, Dušan (Korešpondenčný autor) [UKOLJ110A] (15%) - Dvorská, Dana (Autor) [UKOLJ110A] (15%) - Ňachajová, Marcela (Autor) [UKOLJ150] (5%) - Fiolka, Roman (Autor) (5%) - Grendár, Marián (Autor) [UKOLJ110] (10%) - Hatok, Jozef (Autor) [UKOLJ111] (2%) - Kubatka, Peter (Autor) [UKOLJ120] (2%) - Holubeková, Veronika (Autor) [UKOLJ110C] (9%) - Halašová, Erika (Autor) [UKOLJ120] (5%) - Bielik, Tibor (Autor) [UKOLJ150] (2%) - Žúbor, Pavol (Autor) [UKOLJ150] (10%): Methylation status of KLF4 and HS3ST2 genes as predictors of endometrial cancer and hyperplastic endometrial lesions. International Journal of Molecular Medicine, Roč. 42, č. 6 (2018), s. 3318-3328, IF: 2,928 - 2018. Ohlasy: 16.

5

Danková, Zuzana (Korešpondenčný autor) [UKOLJ110C] (20%) - Žúbor, Pavol (Autor) [UKOLJ150] (10%) - Grendár, Marián (Autor) [UKOLJ110] (10%) - Zelinová, Katarína (Autor) [Interný doktorand] [UKOLJ150] (8%) - Jagelková, Marianna (Autor) [Interný doktorand] [UKOLJ150] (8%) - Šťastný, Igor (Autor) [Interný doktorand] [UKOLJ150] (5%) - Kapinová, Andrea (Autor) [UKOLJ110C] (8%) - Vargová, Daniela (Autor) (6%) - Kasajová, Petra (Autor) [UKOLJ150] (5%) - Dvorská, Dana (Autor) [UKOLJ110A] (5%) - Kalman, Michal (Autor) (5%) - Danko, Ján (Autor) [UKOLJ150] (5%) - Lasabová, Zora (Autor) [UKOLJ121] (5%): Predictive accuracy of the breast cancer genetic risk model based on eight common genetic variants: The BACkSIDE study. Journal of Biotechnology , 1873-4863. – č. 299 (2019), s. 1-7, IF: 3,503 - 2019. Ohlasy: 3.

VI.3 - The most significant research/artistic/other outputs over the last six years
1

Baranovičová, Eva - Račay, Peter - Žúbor, Pavol - Smolár, Marek - Kúdelová, Eva - Halašová, Erika - Dvorská, Dana - Danková, Zuzana: Circulating metabolites in the early stage of breast cancer were not related to cancer stage or subtypes but associated with ki67 level: promising statistical discrimination from controls. Molecular and Cellular Probes, 66 (2022), s. [1-9]. IF: 3.3 - 2022, Ohlasy: 6

2

Šoltýsová, Andrea (Autor) [UKOPRBMB] (5.266%) - Dvorská, Dana (Autor) [UKOLJ110] (5.263%) - Horváthová Kajabová, Viera (Autor) (5.263%) - Pečimonová, Martina (Autor) [UKOPRBMB] (5.263%) - Čepčeková, Klaudia (Autor) [Interný doktorand] [UKOPRBMB] (5.263%) - Ficek, Andrej (Autor) [UKOPRBMB] (5.263%) - Demková, Lucia (Autor) (5.263%) - Buociková, Verona (Autor) (5.263%) - Babál, Pavel (Autor) [UKOLFUPA] (5.263%) - Juráš, Ivan (Autor) (5.263%) - Janíková, Katarína (Autor) [UKOLJ110] (5.263%) - Kašubová, Ivana (Autor) [UKOLJ110] (5.263%) - Samec, Marek (Autor) [UKOLJ261] (5.263%) - Braný, Dušan (Autor) [UKOLJ110] (5.263%) - Lysková, Darina (Autor) [Externý doktorand] [UKOLFKO] (5.263%) - Valášková, Jela (Autor) [UKOLFKO] (5.263%) - Danková, Zuzana (Autor) [UKOLJ110] (5.263%) - Smolková, Božena (Korešpondenčný autor) (5.263%) - Furdová, Alena (Autor) [UKOLFKO] (5.263%): Uncovering accurate prognostic markers for high-risk uveal melanoma through DNA methylation profiling. Clinical and translational medicine, Roč. 13, č. 7 (2023), IF: 7.9 - 2023, Ohlasy: 3.

3

Baranová, Ivana (Autor) [UKOLJ110] (23%) - Samec, Marek (Korešpondenčný autor) [UKOLJ120] (20%) - Dvorská, Dana (Autor) [UKOLJ110] (20%) - Šťastný, Igor (Autor) (5%) - Janíková, Katarína (Autor) (5%) - Kašubová, Ivana (Autor) [UKOLJ110] (5%) - Hornáková, Andrea (Autor) [UKOLJ110] (3%) - Lukáčová, Eva (Autor) (3%) - Kapinová, Andrea (Autor) [UKOLJ110] (2%) - Biringer, Kamil (Autor) [UKOLJ150] (2%) - Halašová, Erika (Autor) [UKOLJ120] (2%) - Danková, Zuzana (Autor) [UKOLJ110] (10%): Droplet digital PCR analysis of CDH13 methylation status in Slovak women with invasive ductal breast cancer. Scientific reports, 14: č. 26 (2024), IF: 3.8 - 2023, Ohlasy: 1.

4

Holubeková, V. - Kolková, Z. - Grendár, M. - Braný, D. - Dvorská, D. - Šťastný, I. - Jagelková, M. - Zelinová, K. - Samec, M. - Mazuráková, A. - Laučeková, Z. - Kúdela, E. - Bobrovská, M. - Kalman, M. - Žúbor, P. - Danková, Z. (2020). Pathway analysis of selected circulating mirnas in plasma of breast cancer patients: A preliminary study. International journal of molecular sciences. Roč. 21, č. 19, s. 1-16. 2020: 5,924-IF, Q1/Q2-JCR, Q1/Q2-SJR. Ohlasy: 17.

5

Danková, Z. - Nováková, E. - Škereňová, M. - Holubeková, V. - Lučanský, V. - Dvorská, D. - Braný, D. - Kolková, Z. - Strnádel, J. - Meršaková, S. - Janíková, K. - Samec, M. - Pokusa, M. - Petráš, M. - Šarlinová, M. - Kašubová, I. - Loderer, D. - Sadloňová, V. - Kompaníková, J. - Kotlebová, N. - Kompaníková, A. - Hrnčiarová, M. - Štanclová, A. - Antošová, M. - Dzian, A. - Nosáľ, V. - Kocan, I. - Murgaš, D. - Krkoška, D. - Čalkovská, A. - Halašová, E. (2021) Comparison of SARS-CoV-2 Detection by Rapid Antigen and by Three Comercial RT-qPCR Tests: a Study from Martin University Hospital in Slovakia. International journal of enviromental research and public health. Roč.18., č. 13, s. 1-16. 2021: 4,614-IF, Q1/Q2-JCR, Q1/Q2-SJR. Ohlasy: 9. 

VI.4 - The most significant citations corresponding to the research/artistic/other outputs
1

Citation: [o1] 2021 Adam-Artigues, A. - Garrido-Cano, I. - Carbonell-Asins, J. A. - Lameirinhas, A. - Simón, S. - Ortega-Morillo, B. - Martínez, M. T. - Hernando, C. - Constâncio, V. - Burgues, O. - Bermejo, B. - Henrique, R. - Lluch, A. - Jerónimo, C.- Eroles, P. - Cejalvo, J. M.: Cancers, roč. 13, č. 11, 2021. Cited article: Holubeková V., Kolková Z.... et Danková Z. Pathway analysis of selected circulating miRnas in plasma of breast cancer patients: A preliminary study. IJMS, 2019, 21:19 (1-16).

2

Citation: [o1] 2021 Mahmoud, M. M. - Sanad, E. F. - Elshimy, R. A. A. - Hamdy, N. M.: Frontiers in Oncology, č. 11, 2021, čl. č. 749753. Cited article: Zubor P, Kubatka P, Kajo K, Dankova Z, et al. Why the Gold Standard Approach by Mammography Demands Extension by Multiomics? Application of Liquid Biopsy miRNA Profiles to Breast Cancer Disease Management. IJMS, 2019, 20:12 (1-31).

3

Citation: [o1] 2021 Adeshakin, F. O. - Adeshakin, A. O. - Afolabi, L. O. - Yan, D. - Zhang, G. - Wan, X.: Frontiers in Oncology, roč. 11, 2021, čl. č. 626577. Cited article: Zubor P*, Dankova Z*. et al. Rho GTPases in Gynecologic Cancers: In-Depth Analysis toward the Paradigm Change from Reactive to Predictive, Preventive, and Personalized Medical Approach Benefiting the Patient and Healthcare. Cancers, 2021, 12:2 (1-37).

4

Citation: [o1] 2020 Pagano, M. - Mosca, L. - Vitiello, F. - Ilisso, C. P. - Coppola, A. - Borzacchiello, L. - Mele, L. - Caruso, F. P. - Ceccarelli, M. - Garaglia, M. Cacciapouti, G. - Porcelli, M.: Cancers, roč. 12, č. 12, 2020, čl. č. 3665. Cited article: Zubor P*, Kubatka P*, Dankova Z*. et al. miRNA in a multiomic context for diagnosis, treatment monitoring and personalized management of metastatic breast cancer. Future Oncology, 2018, 14:18 (1846-1866).

5

Citation: [o1] 2021 Peng, P. H. - Lai, J. C. Y. - Chang, J. S. - Hsu, K. W. - Wu, K. J.: American Journal of Cancer Research, roč. 11, č. 6, 2021, s. 2618-2636. Cited article: Kapinova A, ... Dankova Z,... Danko J. The hypoxia-responsive long non-coding RNAs may impact on the tumor biology and subsequent management of breast cancer. Biomedicine & Pharmacotherapy. 2018, 99 (51-58).

VI.5 - Participation in conducting (leading) the most important research projects or art projects over the last six years
1

Systemic Public Research Infrastructure - Biobank for Cancer and Rare diseases, BIOFORD, ITMS: 313011AFG5. Period: 2020-2023. Position: director. Aim: Building a systematic and functional infrastructure of modern biobanking. Link: https://www.jfmed.uniba.sk/fileadmin/jlf/Pracoviska/centrum-pre-podporu-vedy-vyskumu-a-vyvoja/2020/Info_BIOGORD.pdf or https://www.biobankslovakia.sk/ 

2

New possibilities of laboratory diagnostics and massive screening of SARS-Cov-2 and identification of mechanisms of virus behavior in the human body. ITMS 313011AUA4. Period: 2020-2023. Position: researcher. Aim: NGS diagnostics, cellular and immune response, virus detection in wastewater, genetic advantage, metabolomics. Link: https://www.jfmed.uniba.sk/fileadmin/jlf/Pracoviska/centrum-pre-podporu-vedy-vyskumu-a-vyvoja/2022/webpage_COVLAB.pdf 

3

Integrative strategy in the development of personalized medicine of selected cancers and its impact on quality of life. ITMS 313011V446. Period: 2020-2023. Position: researcher. Aim: Personalized diagnostics and therapy, identification of new genetic markers, modern algorithms. Link: https://www.jfmed.uniba.sk/fileadmin/jlf/Pracoviska/centrum-pre-podporu-vedy-vyskumu-a-vyvoja/2020/web_LISPER.docx.pdf

4

DNA methylation as a target for epigenetic editing and its use in personalizing the diagnosis and therapy of melanoma uvey. APVV_BMC 17-0369. Period: 2018-2022. Position: project partner. Aim: based on the epigenomic analyzes, detect specificaly methylated genes and verify the possibility of their editing in vitro and in vivo.

5

The role of microRNAs in breast cancer: biological significance, targeted molecules and signaling pathways. APVV 16-0021. Period: 2018-2021. Finalised. Position: principal investigator since 2019. Aim: miRNA profile, methylation status, expression, function pathways.

VII. - Overview of organizational experience related to higher education and research/artistic/other activities

VIII. - Overview of international mobilities and visits oriented on education and research/artistic/other activities in the given field of study

IX. - Other relevant facts

IX.a - If relevant, other activities related to higher education or research/artistic/other activities are mentioned

Member of the Academic senate of the JFMED UK, 2021-2023.

Member of the Academic senate of the Faculty of Natural Sciences UK, 2014-2016.

Date of last update
2025-02-26